Tactile Imaging and Electromyography



Status:Enrolling by invitation
Conditions:Overactive Bladder, Urology
Therapuetic Areas:Gastroenterology, Nephrology / Urology
Healthy:No
Age Range:21 - Any
Updated:3/21/2019
Start Date:December 24, 2017
End Date:June 30, 2019

Use our guide to learn which trials are right for you!

Tactile Imaging and Electromyography of Female Pelvic Floor

Urinary incontinence (UI) and overactive bladder (OAB) in women has high prevalence which is
increasing with the age. In adults aged 40 and older in the US demonstrated prevalence rate
of 27.2% among man and 43.1% among women, respectively. Urine Incontinence was reported to
affect 15% of women ages 40 to 49, 25% ages 60 to 69, and 38% of women age 80 and older.

Pelvic floor disorders result from neuro-urinary pathology as well as muscle functional
impairment due to changes in bio-mechanical properties of soft tissues with the age. That is
why pelvic floor characterization and diagnosis must include electomyographic (EMG) and
biomechanical measurements (pressure) or better if EMG and tactile imaging with improved
spatial resolution. The quantitative and objective imaging data for pelvic floor conditions
could allow an effective treatment of OAB and UI.

In this research the investigators propose to develop a new device for accurate diagnosis of
the diseased conditions by measuring the pelvic floor muscles strength and EMG activity. The
value to society is high given by the prevalence of OAB and UI.

Inclusion Criteria:

- Women above age of 21 with normal pelvic floor condition for the control

- Women with SUI conditions as defined by International Continence Society guidelines

- Women with OAB conditions as defined by American Urological Association and Society of
Urodinamics, Female Pelvic Medicine & Urogenital Reconstruction.

Exclusion Criteria:

- Any prior pelvic floor surgery related to SUI, POP or OAB conditions

- Active skin infection or ulceration within the vagina

- Presence of the vaginal septum

- Active cancer of the colon, rectum wall, cervix, vaginal, uterus or bladder

- Ongoing radiation therapy for pelvic cancer; impacted stool

- Surgically absent rectum or bladder

- Sever hemorrhoids

- Significant circulatory or cardiac conditions that could cause excessive risk

- Significant pre-existing pelvic pain including levator ani syndrome, severe vaginismus
or vulvodynia.
We found this trial at
1
site
Princeton, New Jersey 08540
?
mi
from
Princeton, NJ
Click here to add this to my saved trials